Reneo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Onkure Therapeutics

11/08/2021 11:26

* Reneo Pharmaceuticals Inc  RPHM.OQ  reported a quarterly
adjusted loss of 43 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 38 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Reneo Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 43 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Reneo Pharmaceuticals Inc shares had fallen by 9.0% this
quarter.
* The company reported a quarterly loss of $9.21 million.
* Wall Street's median 12-month price target for Reneo
Pharmaceuticals Inc is $25.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 10:26 a.m.  ​All
figures in US dollars unless otherwise stated